MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Philadelphia negative myeloproliferative neopl 28 asms (MPNs) are clonal haematological diseases characterized by excessive production of mature blood cells. Exome sequencing of patient samples have showed a relatively low degree genomic complexity for these diseases1. The majority of MPN patients carry somatic mutations in the JAK2 gene, with the JAK2V617F missense mutation being the most common in poly33 cythemia vera (PV, 95%) and essential thrombocythemia (ET, 60%) 2.
Description
Keywords
Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Humans, Janus Kinase 2, Leukemia, Erythroblastic, Acute, MicroRNAs, Mutation, STAT5 Transcription Factor, Signal Transduction, Tumor Cells, Cultured, Tumor Suppressor Proteins
Journal Title
Leukemia
Conference Name
Journal ISSN
0887-6924
1476-5551
1476-5551
Volume Title
32
Publisher
Springer Science and Business Media LLC
Publisher DOI
Sponsorship
Medical Research Council (MC_PC_12009)
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (097922/Z/11/B)
Leukaemia & Lymphoma Research (13003)
Cancer Research UK (21762)
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (097922/Z/11/B)
Leukaemia & Lymphoma Research (13003)
Cancer Research UK (21762)
FP was supported by Fondazione Umberto Veronesi, and Institute Pasteur - Fondazione Cenci Bolognetti.